SP
Therapeutic Areas
Akros Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| JTE-051 | Autoimmune diseases, Allergic diseases | Phase2 |
| JTT-662 | Type 2 diabetes mellitus | Phase1 |
| JTT-861 | Chronic heart failure | Phase2 |
| JTC-064 | Neurodegenerative disease | Phase1 |
| JTV-161 | Pulmonary arterial hypertension | Phase1 |
| JTE-162 | Autoinflammatory/Autoimmune diseases | Phase1 |
| JTC-262 | Neurodegenerative disease | Phase1 |
| JTV-263 | Peripheral artery disease | Phase1 |